Improved prediction of endoxifen metabolism by cyp2d6 genotype in breast cancer patients treated with tamoxifen
10.3389/fphar.2017.00582
Saved in:
Main Authors: | Schroth, W, Winter, S, Mürdter, T, Schaeffeler, E, Eccles, D, Eccles, B, Chowbay, B, Khor, C.C, Tfayli, A, Zgheib, N.K, Eichelbaum, M, Schwab, M, Brauch, H |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/181252 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
by: Li, J, et al.
Published: (2020) -
Photolytic fate of (E)- and (Z)-endoxifen in water and treated wastewater exposed to sunlight
by: Marina Ariño Martin, et al.
Published: (2022) -
Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen
by: Insee Sensorn, et al.
Published: (2018) -
Effect of CYP2D6 polymorphism on Tamoxifen pharmacokinetic in Thai breast cancer patients
by: Pichayapa Rungwanonchai
Published: (2013) -
A miniaturized flow-through cell to evaluate skin permeation of endoxifen
by: Mah, C.S., et al.
Published: (2014)